BioCentury
ARTICLE | Company News

Google's Calico adds Roche's Barron, others to team

November 20, 2013 3:18 AM UTC

Bay Area-based newco Calico announced several additions to its management team on Tuesday, including Hal Barron, who joined as president of R&D. Google Inc. (NASDAQ:GOOG) launched Calico in September to focus on health and well-being, including aging and associated diseases. Barron is CMO and head of global development at Roche (SIX:ROG; OTCQX:RHHBY). Roche's Genentech Inc. unit said Barron will stay on as CMO and head of global development through the end of the year, and that Roche will announce a new head and CMO "in due course." Barron will remain a member of the Roche Late Stage Portfolio Committee and will join Genentech's board.

Calico also hired David Botstein as CSO. Botstein was director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University, where he remains a professor of genomics. Additionally, Bob Cohen joined the newco as a fellow, a role that Calico CEO Arthur Levinson said spans R&D and business development; and Cynthia Kenyon joined as a part-time senior scientific advisor. Cohen was a senior oncology fellow at Genentech. Kenyon is a professor at the University of California, San Francisco and director of the university's Hillblom Center for the Biology of Aging. ...